Pharmaceutical company contracts Memsift for liquid-waste treatment

A major pharmaceutical company contracted Memsift Innovations to design, build, own and operate a liquid-waste treatment system using its TS-30 Improved Membrane Distillation process.

“A major pharmaceutical company has contracted Memsift Innovations Pte Ltd to design, build, own and operate (BOO) a liquid-waste treatment system that is based on its proprietary TS-30 Improved Membrane Distillation (IMD) process.”doi.org

• 1 source
• doi.orgPharmaceutical company selects Memsift technology to treat liquid wasteDec 1, 2019

Summarized from public sources; check the original articles before acting on it.